Overview

Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug

Status:
Completed

Trial end date:
2012-07-01

Target enrollment:

Participant gender:

Summary

An open-label, randomized, multi-centre, superiority study to assess that, in patients who respond to zonisamide added as third drug after failure of a two-drug combination therapy, the triple therapy is superior to the conversion to a double therapy including zonisamide.

Phase:

Phase 4

Details

Lead Sponsor:

Eisai Inc.

Treatments:

Anticonvulsants
Zonisamide